Literature DB >> 2844218

Macromolecular osteolytic factor synthesised by squamous carcinoma cell lines from the head and neck in vitro is interleukin 1.

S Meghji1, J R Sandy, A M Scutt, W Harvey, R L Carter, M Harris.   

Abstract

Three human cell lines derived from oro-pharyngeal squamous cell carcinomas of the head were investigated for bone-resorbing activity in vitro. Culture media from all three spontaneously produced a non-dialysable osteolytic factor with activity in three in vitro assays for interleukin 1 (IL1), viz. the lymphocyte activating factor (LAF) assay, stimulation of collagenase synthesis by articular chondrocytes, and stimulation of prostaglandin E2 synthesis by fibroblasts. Addition of anti-human IL1 antibody to the culture media abolished all the bone-resorbing activity. Fractionation of the cell culture media by high performance liquid chromatography (HPLC) showed a single peak of activity in the chondrocyte assay with an apparent mol.wt of 15-17,000. This co-eluted with activity in a preparation of IL1 from rat peritoneal macrophage cultures. These results indicate that IL1 is responsible for the prostaglandin-independent bone resorbing activity synthesised by these cells in vitro, and may contribute to the bone destruction associated with the tumour.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844218      PMCID: PMC2246480          DOI: 10.1038/bjc.1988.153

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit.

Authors:  E F Voelkel; A H Tashjian; R Franklin; E Wasserman; L Levine
Journal:  Metabolism       Date:  1975-08       Impact factor: 8.694

2.  Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins.

Authors:  C S Galasko; A Bennett
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

3.  Human breast tumour-induced osteolysis and prostaglandins.

Authors:  M Dowsett; G C Easty; T J Powles; D M Easty; A M Neville
Journal:  Prostaglandins       Date:  1976-03

4.  Prostaglandins: stimulation of bone resorption in tissue culture.

Authors:  D C Klein; L G Raisz
Journal:  Endocrinology       Date:  1970-06       Impact factor: 4.736

5.  Evidence for the secretion of an osteoclast stimulating factor in myeloma.

Authors:  G R Mundy; L G Raisz; R A Cooper; G P Schechter; S E Salmon
Journal:  N Engl J Med       Date:  1974-11-14       Impact factor: 91.245

6.  Effect of lesions in the globus pallidus upon thyroid function.

Authors:  P N Cheifetz
Journal:  J Endocrinol       Date:  1969-01       Impact factor: 4.286

7.  Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes.

Authors:  J E Horton; L G Raisz; H A Simmons; J J Oppenheim; S E Mergenhagen
Journal:  Science       Date:  1972-09-01       Impact factor: 47.728

8.  Breast cancer, prostaglandins, and bone metastases.

Authors:  A Bennett; A M McDonald; J S Simpson; I F Stamford
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

9.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.

Authors:  A H Tashjian; E F Voelkel; L Levine; P Goldhaber
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck.

Authors:  P G Sacks
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.